On-demand Testing Solution

The small, quiet, stackable, fully-automated system combines easy-to-use functionality with PCR performance, to bring clinical confidence closer to patients. Has the flexibility to deliver fast individual results.¹

Widest detection of gastrointestinal parasites, with analyte detected 95% of the time in one single assay (25 targets).² A cartridge-based molecular test for qualitative detection of protozoa, helminths and microsporidia.³ Our microarray technology allows for multiplex testing. The test uses stool samples from patients.

Wide detection of gastrointestinal bacteria in one single assay with 14 targets.⁴ A cartridge-based molecular test for qualitative detection of bacterial gastroenteritis. The Novodiag Bacterial GE+ Assay test uses stool samples from patients without preservatives or in FecalSwab.*

Widest detection of resistance genes to carbapenem and colistin in one single assay (10 targets).⁵ A cartridge-based molecular test for qualitative detection of carbapenemases and colistin resistance. The Novodiag CarbaR+ Assay uses rectal swabs and pure cultures from patients.

A cartridge-based molecular test for the detection and differentiation of SARS-CoV-2, Flu A, Flu B and RSV in one single assay.⁶ The test uses nasopharyngeal swab samples from patients.

A cartridge-based RT-PCR test for qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).⁷ The test uses nasopharyngeal swab samples from patients.

A cartridge-based molecular test for qualitative detection of pathogenic Clostridium difficile strains producing toxin B.⁸ The test uses stool samples from patients (without preservatives or in FecalSwabTM).*